Diabetes is a clinical condition where the glucose level in blood increases due to inefficiency of pancreas to produce insulin. Diabetes management is used to control the blood sugar levels, which can be monitored by using blood glucose meters. Self-monitoring blood glucose devices are used to track and monitor blood glucose levels in diabetic patients.

The self-monitoring blood glucose devices market is anticipated to exhibit significant growth in the near future, owing to factors such as rise in prevalence of diabetes, surge in obese population who are prone to diabetes, technological advancements in diabetes devices, and surge in need for faster & safer diagnosis as well as treatment of diabetes.

However, blood glucose monitoring devices do not measure the exact level of glucose in blood, whereas provide the readings in the form of a particular range. In addition, adverse effects associated with some of the diabetes care devices hinder the market growth. Rise in awareness about diabetes monitoring devices and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.

Download sample copy @ https://www.alliedmarketresearch.com/request-sample/4149

Key findings:

• Blood glucose meters accounted for more than one-eighth of the share of the self-monitoring blood glucose devices market in 2017.
• The type 1 diabetes segment is anticipated to grow with the moderate CAGR throughout the forecast period.
• Europe accounted for more than one-fourth of the global self-monitoring blood glucose devices market in 2017.
• The LAMEA region is anticipated to grow at the high rate in the self-monitoring blood glucose devices market during the study period.

By product, the test strips segment accounted for the maximum share of the global self-monitoring blood glucose devices market in 2017 and is projected to exhibit prominent growth rate, owing to increase in demand for test strips in various diabetes monitoring devices.

North America accounted for more than two-fifths share of the global market in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of diabetes, growth in geriatric population, and adoption of sedentary lifestyle of people that leads to diabetes. In addition, high adoption rate of technologically advanced devices and presence of sophisticated healthcare infrastructure are expected to offer new growth opportunities to the market players in future.

The key players profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic plc, PHC Holdings Corporation, Sanofi, Terumo Corporation, and Trividia Health, Inc.

Send Enquiry us @ https://www.alliedmarketresearch.com/purchase-enquiry/4149